Status:
UNKNOWN
Predictive Value of Neuromuscular Ultrasound of Cranial Nerves in Guillain-Barré Syndrome
Lead Sponsor:
Assiut University
Conditions:
Guillain-Barre Syndrome
Eligibility:
All Genders
18-65 years
Brief Summary
1. Sensitivity and specificity of cranial neuromuscular US to detect the prognosis of Guillain Barre Syndrome 2. Correlation of US values with motor, respiratory and autonomic complications of Guillai...
Detailed Description
Guillain-Barré syndrome (GBS) is a dangerous and under certain circumstances life-threatening immune-mediated polyneuropathy of acute onset, often subsequent to respiratory or diarrheal illness. Patie...
Eligibility Criteria
Inclusion
- Patients fulfilling the diagnostic criteria of GBS within the first 2 weeks.
- Age: 18-65
- Both sexes
Exclusion
- Past history of previous similar condition or history suggestive of CIDP.
- Any proved alternative diagnosis like hypo- or hyperkalemic paralysis, porphyria, or myositis.
- Other possible causes of peripheral neuropathy, diabetes, renal, and other metabolic disorders.
- History of Autonomic or cardiopulmonary dysfunction before the onset of symptoms.
- Patients who refused to participate or sign an informed consent.
Key Trial Info
Start Date :
January 8 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 8 2025
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT06200454
Start Date
January 8 2024
End Date
June 8 2025
Last Update
January 11 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.